<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04485897</url>
  </required_header>
  <id_info>
    <org_study_id>895689</org_study_id>
    <nct_id>NCT04485897</nct_id>
  </id_info>
  <brief_title>Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring</brief_title>
  <official_title>Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a
      group of diseases that lead to optic nerve damage and corresponding deterioration of the
      visual field.

      Elevated intraocular pressure remains the most important risk factor. Interestingly,
      glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure.

      Recent studies suggest pressure peaks, which are missed under the current practice of spot
      intraocular measurements during office hours. In order to detect pressure peaks diurnal
      measurements are mandatory. Costly in-hospital diurnal measurements are the current standard.

      The primary study objective is to verify that self-tonometry at home can provide valuable
      information when looking for pressure peaks in patients with glaucoma.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of an in- hospital diurnal pressure pattern of intraocular pressure to the pattern derived from self-tonometry using icare HOME in an outpatient setting.</measure>
    <time_frame>4 years</time_frame>
    <description>Statistical methods for analysis of continuous method comparison data will be applied. The primary goal is to quantify the extent of agreement between two methods (Intraocular pressure measurement in-hospital and at home) and determine whether they sufficiently agree to be used interchangeably.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>variance of diurnal intraocular pressure</measure>
    <time_frame>4 years</time_frame>
    <description>Quantitative evaluation of day to day variance of diurnal intraocular pressure measurement in an out-hospital setting in patients with open angle glaucoma, normal tension glaucoma and healthy controls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of daily activities</measure>
    <time_frame>4 years</time_frame>
    <description>Influence of daily activities (sports, alcohol and water intake) on intraocular measurements at home (questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of treatment</measure>
    <time_frame>4 years</time_frame>
    <description>Change of treatment due to intraocular pressure peaks during hospitalisation and/or measurements at home</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Intraocular Pressure</condition>
  <arm_group>
    <arm_group_label>icare HOME</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>icare HOME device (Icare Oy, Vanda, Finland)</intervention_name>
    <description>icare HOME device versus hospital based measurements</description>
    <arm_group_label>icare HOME</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Subjects aged 18 and older

          -  Glaucoma patients and healthy controls

          -  Best corrected visual acuity &gt;0.1

          -  Astigmatism ≤ 3dpt.

          -  Good compliance

          -  Central corneal thickness (400-650μm)

          -  Passed certification procedure (detailed description under: Measurements and
             procedures)

          -  Therapeutic regimen unchanged throughout the past 30 days

        Exclusion Criteria:

          -  History of ocular trauma

          -  Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual
             acuity &lt;0.1

          -  Physical or mental disability interfering with self-tonometry (e.g. arthritis,
             Parkinson's disease)

          -  Dry eye disease

          -  Known or suspected non-compliance, drug or alcohol abuse

          -  Inability to follow the procedures of the study, e.g. due to language problems,
             psychological disorders, dementia, etc. of the participant

          -  Pregnancy

          -  Breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Raphael Fritsche, MD</last_name>
    <phone>0041 205 33 76</phone>
    <email>raphael.fritsche@luks.ch</email>
  </overall_contact>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 3, 2020</study_first_submitted>
  <study_first_submitted_qc>July 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Luzerner Kantonsspital</investigator_affiliation>
    <investigator_full_name>Raphael Fritsche</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>self-monitoring</keyword>
  <keyword>intraocular pressure</keyword>
  <keyword>icare HOME</keyword>
  <keyword>rebound tonometry</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

